JP2005519095A5 - - Google Patents

Download PDF

Info

Publication number
JP2005519095A5
JP2005519095A5 JP2003572556A JP2003572556A JP2005519095A5 JP 2005519095 A5 JP2005519095 A5 JP 2005519095A5 JP 2003572556 A JP2003572556 A JP 2003572556A JP 2003572556 A JP2003572556 A JP 2003572556A JP 2005519095 A5 JP2005519095 A5 JP 2005519095A5
Authority
JP
Japan
Prior art keywords
maltitol
cariogenic
insensitive
sweet
diluent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003572556A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005519095A (ja
Filing date
Publication date
Priority claimed from SE0200657A external-priority patent/SE0200657D0/xx
Application filed filed Critical
Publication of JP2005519095A publication Critical patent/JP2005519095A/ja
Publication of JP2005519095A5 publication Critical patent/JP2005519095A5/ja
Withdrawn legal-status Critical Current

Links

JP2003572556A 2002-03-04 2003-03-03 新規製剤 Withdrawn JP2005519095A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0200657A SE0200657D0 (sv) 2002-03-04 2002-03-04 Novel Formulation
PCT/SE2003/000371 WO2003074036A1 (en) 2002-03-04 2003-03-03 Novel formulation

Publications (2)

Publication Number Publication Date
JP2005519095A JP2005519095A (ja) 2005-06-30
JP2005519095A5 true JP2005519095A5 (enExample) 2006-04-20

Family

ID=20287162

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003572556A Withdrawn JP2005519095A (ja) 2002-03-04 2003-03-03 新規製剤

Country Status (6)

Country Link
US (1) US20050152847A1 (enExample)
EP (1) EP1487423A1 (enExample)
JP (1) JP2005519095A (enExample)
AU (1) AU2003217110A1 (enExample)
SE (1) SE0200657D0 (enExample)
WO (1) WO2003074036A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006528228A (ja) * 2003-05-22 2006-12-14 アルタナ ファルマ アクチエンゲゼルシャフト サルメテロール及びシクレソニドの組合せ物
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
WO2009026434A1 (en) * 2007-08-21 2009-02-26 Alkermes, Inc. Pulmonary pharmaceutical formulations
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
CA2705681C (en) 2007-11-13 2013-06-18 Meritage Pharma, Inc. Corticosteroid compositions
US20090123390A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
EP2990056A4 (en) * 2013-04-22 2016-12-14 Tochigi Inst Of Clinical Pathology CANCER AGENT

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2588005B1 (fr) * 1985-10-02 1987-12-11 Roquette Freres Maltitol poudre directement compressible et son procede de preparation
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5747445A (en) * 1993-06-24 1998-05-05 Astra Aktiebolag Therapeutic preparation for inhalation
US6290991B1 (en) * 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
SE9700136D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700134D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9404468D0 (sv) * 1994-12-22 1994-12-22 Astra Ab Powder formulations
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
CA2387212A1 (en) * 1999-10-12 2001-04-19 Kaken Pharmaceutical Co., Ltd. Dry powder inhalation and a method for the preparation thereof

Similar Documents

Publication Publication Date Title
JP2005519095A5 (enExample)
US20020147201A1 (en) Water soluble and palatable complexes
JP5566408B2 (ja) ドライシロップ剤
EP2893940A2 (en) Granulated material for tablet that rapidly disintegrates in mouth
JP2009510068A5 (enExample)
JP2009532343A (ja) 口腔内崩壊錠剤のための直接圧縮性複合材
WO2001039745A3 (en) Aerosol composition comprising formoterol
ITMI971746A1 (it) Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
CN101102748A (zh) 具有感觉提示剂的在口中分裂的药物组合物
JP5630902B2 (ja) ゾルピデム酒石酸塩含有口腔内崩壊錠の製造方法
JP2022088683A (ja) 医薬組成物
JP2010270110A (ja) ネオテームを含有する経口製剤
JP5291324B2 (ja) 口腔内崩壊錠
KR20110112304A (ko) 붕괴성 및 용출성에 우수한 내복용 정제
JP2004043475A (ja) 経口用セファロスポリン製剤
WO2015198483A1 (ja) 賦形剤造粒物、及び錠剤
JPH0827033A (ja) エリスリトール含有固形剤
JP6088848B2 (ja) 賦形剤造粒物及びその製造方法、並びに錠剤
WO2010119851A1 (ja) 口腔内崩壊錠
JP2005232072A (ja) 高湿度及び低湿度下で安定なフィルム製剤及びフィルム食品
JP2009514857A5 (enExample)
CN1717245A (zh) 医药组合物
US20080227849A1 (en) Orally Disintegrable Solid Preparation Comprising Povidone-Iodine
JP2000007556A (ja) チュアブル錠
KR100730393B1 (ko) 이부프로펜 및 아르기닌을 함유하는 약학 조성물의제조방법